Glucocorticoid receptor-mediated transcriptional regulation of N-acetyltransferase 1 gene through distal promoter

AAPS Journal

Volumn 14, Issue 3, 2012, Pages 581-590

  Bonamassa, Barbara ^a   Ma, Yongjie ^a   Liu, Dexi ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

arylamine N acetyltransferases; glucocorticoids; phase II enzymes; promoter analysis; regulation of gene expression; transcriptional regulation

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; ARYLAMINE N ACETYLTRANSFERASE 1; CARCINOGEN; CELL NUCLEUS RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; DEXAMETHASONE; ENZYME; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; MIFEPRISTONE; PREGNANE X RECEPTOR; RETINOIC ACID RECEPTOR; RETINOID RELATED ORPHAN RECEPTOR ALPHA; UNCLASSIFIED DRUG; XENOBIOTIC METABOLIZING ENZYME;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASSAY; CARCINOGENESIS; CELL STRAIN HEPG2; DNA FLANKING REGION; DRUG TRANSFORMATION; ENVIRONMENTAL FACTOR; GENE DELETION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYDRODYNAMICS; LIVER CELL CULTURE; MOUSE; NONHUMAN; PROMOTER REGION; REPORTER GENE; RNA TRANSLATION; TRANSCRIPTION REGULATION;

ANIMALS; ARYLAMINE N-ACETYLTRANSFERASE; BASE SEQUENCE; CELL LINE; DNA PRIMERS; GENE EXPRESSION REGULATION; HUMANS; ISOENZYMES; MALE; MICE; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, GLUCOCORTICOID; TRANSCRIPTION, GENETIC;

EID: 84862760952     PISSN: 15507416     EISSN: None     Source Type: Journal    
DOI: 10.1208/s12248-012-9370-5     Document Type: Article

References (47)

1. DW Hein 2002 Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis Mutat Res 506-507 65 77 12351146
2. DW Hein 2006 N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk Oncogene 25 1649 1658 16550165 10.1038/sj.onc.1209374 1:CAS:528:DC%2BD28XisFyhtbs%3D
3. AF Badawi A Hirvonen DA Bell NP Lang FF Kadlubar 1995 Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder Cancer Res 55 5230 5237 7585581 1:CAS:528: DyaK2MXpsVaru7w%3D
4. PJ Adam J Berry JA Loader KL Tyson G Craggs P Smith J De Belin G Steers F Pezzella KF Sachsenmeir AC Stamps A Herath E Sim MJ O'Hare AL Harris JA Terrett 2003 Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro Mol Cancer Res 1 826 835 14517345 1:CAS:528:DC%2BD3sXns1eltbw%3D
5. I Bieche I Girault E Urbain S Tozlu R Lidereau 2004 Relationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinoma Breast Cancer Res 6 R252 R263 15084249 10.1186/bcr784
6. L Wakefield J Robinson H Long JC Ibbitt S Cooke HC Hurst E Sim 2008 Arylamine N-acetyltransferase 1 expression in breast cancer cell lines: a potential marker in estrogen receptor-positive tumors Genes Chromosomes Cancer 47 118 126 17973251 10.1002/gcc.20512 1:CAS:528:DC%2BD1cXmtV2qsA%3D%3D
7. SJ Kim HS Kang HL Chang YC Jung HB Sim KS Lee J Ro ES Lee 2008 Promoter hypomethylation of the N-acetyltransferase 1 gene in breast cancer Oncol Rep 19 663 668 18288399 1:CAS:528:DC%2BD1cXjs1elsrw%3D
8. JH Lee HF Lu DY Wang DR Chen CC Su YS Chen JH Yang JG Chung 2004 Effects of tamoxifen on DNA adduct formation and arylamines N-acetyltransferase activity in human breast cancer cells Res Commun Mol Pathol Pharmacol 115-116 217 233 17564319
9. N Ragunathan J Dairou B Pluvinage M Martins E Petit N Janel JM Dupret F Rodrigues-Lima 2008 Identification of the xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 as a new target of cisplatin in breast cancer cells: molecular and cellular mechanisms of inhibition Mol Pharmacol 73 1761 1768 18310302 10.1124/mol.108.045328 1:CAS:528:DC%2BD1cXms1ems70%3D
10. F Malka J Dairou N Ragunathan JM Dupret F Rodrigues-Lima 2009 Mechanisms and kinetics of human arylamine N-acetyltransferase 1 inhibition by disulfiram FEBS J 276 4900 4908 19664055 10.1111/j.1742-4658.2009.07189.x 1:CAS:528:DC%2BD1MXhtVKmtLjO
11. J Lapointe C Li JP Higgins M van de Rijn E Bair K Montgomery M Ferrari L Egevad W Rayford U Bergerheim P Ekman AM DeMarzo R Tibshirani D Botstein PO Brown JD Brooks JR Pollack 2004 Gene expression profiling identifies clinically relevant subtypes of prostate cancer Proc Natl Acad Sci U S A 101 811 816 14711987 10.1073/pnas.0304146101 1:CAS:528:DC%2BD2cXhsVWhu7o%3D
12. NJ Butcher RF Minchin 2010 Arylamine N-acetyltransferase 1 gene regulation by androgens requires a conserved heat shock element for heat shock factor-1 Carcinogenesis 31 820 826 20176657 10.1093/carcin/bgq042 1:CAS:528:DC%2BC3cXlvVWjsrc%3D
13. L Wakefield S Boukouvala E Sim 2010 Characterisation of CpG methylation in the upstream control region of mouse Nat2: evidence for a gene-environment interaction in a polymorphic gene implicated in folate metabolism Gene 452 16 21 20026257 10.1016/j.gene.2009.12.002 1:CAS:528:DC%2BC3cXpsVaitQ%3D%3D
14. NJ Butcher A Arulpragasam C Pope RF Minchin 2003 Identification of a minimal promoter sequence for the human N-acetyltransferase type I gene that binds AP-1 (activator protein 1) and YY-1 (Yin and Yang 1) Biochem J 376 441 448 12946272 10.1042/BJ20030650 1:CAS:528:DC%2BD3sXptFOqsro%3D
15. A Husain X Zhang MA Doll JC States DF Barker DW Hein 2007 Functional analysis of the human N-acetyltransferase 1 major promoter: quantitation of tissue expression and identification of critical sequence elements Drug Metab Dispos 35 1649 1656 17591675 10.1124/dmd.107.016485 1:CAS:528: DC%2BD2sXpslKqs7Y%3D
16. A Husain DF Barker JC States MA Doll DW Hein 2004 Identification of the major promoter and non-coding exons of the human arylamine N-acetyltransferase 1 gene (NAT1) Pharmacogenetics 14 397 406 15226672 10.1097/01.fpc.0000114755. 08559.6e 1:CAS:528:DC%2BD2cXlt1Cktro%3D
17. S Boukouvala E Sim 2005 Structural analysis of the genes for human arylamine N-acetyltransferases and characterisation of alternative transcripts Basic Clin Pharmacol Toxicol 96 343 351 15853926 10.1111/j.1742-7843.2005.pto- 02.x 1:CAS:528:DC%2BD2MXktlansLw%3D
18. NJ Butcher A Arulpragasam HL Goh T Davey RF Minchin 2005 Genomic organization of human arylamine N-acetyltransferase type I reveals alternative promoters that generate different 5′-UTR splice variants with altered translational activities Biochem J 387 119 127 15487985 10.1042/BJ20040903 1:CAS:528:DC%2BD2MXisFWgt78%3D
19. DF Barker A Husain JR Neale BD Martini X Zhang MA Doll JC States DW Hein 2006 Functional properties of an alternative, tissue-specific promoter for human arylamine N-acetyltransferase 1 Pharmacogenet Genomics 16 515 525 16788383 10.1097/01.fpc.0000215066.29342.26 1:CAS:528:DC%2BD28XlvFyksL4%3D
20. NJ Butcher NL Tetlow C Cheung GM Broadhurst RF Minchin 2007 Induction of human arylamine N-acetyltransferase type I by androgens in human prostate cancer cells Cancer Res 67 85 92 17210686 10.1158/0008-5472.CAN-06-2635 1:CAS:528:DC%2BD2sXisFWgsA%3D%3D
21. KR Mitchell D Warshawsky 2003 Xenobiotic inducible regions of the human arylamine N-acetyltransferase 1 and 2 genes Toxicol Lett 139 11 23 12595154 10.1016/S0378-4274(02)00437-X 1:CAS:528:DC%2BD3sXht1Gnsbo%3D
22. TC Hsia JH Yang HJ Lin CS Yu FS Yu JG Chung 2004 Paclitaxel inhibits N-acetyltransferase activity and gene expression in human stomach tumor cells (SC-M1) Res Commun Mol Pathol Pharmacol 115-116 21 38 17564303
23. FS Yu CS Yu JP Lin SC Chen WW Lai JG Chung 2005 Diallyl disulfide inhibits N-acetyltransferase activity and gene expression in human esophagus epidermoid carcinoma CE 81T/VGH cells Food Chem Toxicol 43 1029 1036 15833378 10.1016/j.fct.2005.02.009 1:CAS:528:DC%2BD2MXjt1Sru7k%3D
24. KC Cheng YC Li CS Yu FS Yu JH Lee ML Lin JS Yang JG Chung 2006 Ketoprofen-inhibited N-acetyltransferase activity and gene expression in human colon tumor cells Anticancer Res 26 1105 1111 16619513 1:CAS:528: DC%2BD28XktFWmsL0%3D
25. WM Westerink WG Schoonen 2007 Phase II enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells Toxicol In Vitro 21 1592 1602 17716855 10.1016/j.tiv.2007.06.017 1:CAS:528:DC%2BD2sXhtlWrsrvO
26. SA Bustin V Benes JA Garson J Hellemans J Huggett M Kubista R Mueller T Nolan MW Pfaffl GL Shipley J Vandesompele CT Wittwer 2009 The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments Clin Chem 55 611 622 19246619 10.1373/clinchem.2008.112797 1:CAS:528: DC%2BD1MXktVWqs7g%3D
27. SA Bustin JF Beaulieu J Huggett R Jaggi FS Kibenge PA Olsvik LC Penning S Toegel 2010 MIQE precis: practical implementation of minimum standard guidelines for fluorescence-based quantitative real-time PCR experiments BMC Mol Biol 11 74 20858237 10.1186/1471-2199-11-74
28. F Liu Y Song D Liu 1999 Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA Gene Ther 6 1258 1266 10455434 10.1038/sj.gt.3300947 1:CAS:528:DyaK1MXksVKht74%3D
29. O Heikinheimo K Kontula H Croxatto I Spitz T Luukkainen P Lahteenmaki 1987 Plasma concentrations and receptor binding of RU 486 and its metabolites in humans J Steroid Biochem 26 279 284 3560943 10.1016/0022-4731(87)90083-5 1:CAS:528:DyaL2sXktlegtL8%3D
30. G Fakis S Boukouvala V Buckle M Payton C Denning E Sim 2000 Chromosome mapping of the genes for murine arylamine N-acetyltransferases (NATs), enzymes involved in the metabolism of carcinogens: identification of a novel upstream noncoding exon for murine Nat2 Cytogenet Cell Genet 90 134 138 11060463 10.1159/000015648 1:CAS:528:DC%2BD3cXotVKisbY%3D
31. S Boukouvala N Price KE Plant E Sim 2003 Structure and transcriptional regulation of the Nat2 gene encoding for the drug-metabolizing enzyme arylamine N-acetyltransferase type 2 in mice Biochem J 375 593 602 12904181 10.1042/BJ20030812 1:CAS:528:DC%2BD3sXotlehs74%3D
32. OJ Schoneveld IC Gaemers WH Lamers 2004 Mechanisms of glucocorticoid signalling Biochim Biophys Acta 1680 114 128 15488991 1:CAS:528: DC%2BD2cXos1ens74%3D
33. S Wieland MD Schatt S Rusconi 1990 Role of TATA-element in transcription from glucocorticoid receptor-responsive model promoters Nucleic Acids Res 18 5113 5118 2402438 10.1093/nar/18.17.5113 1:CAS:528:DyaK3cXmtVGqsLk%3D
34. HM Jantzen U Strahle B Gloss F Stewart W Schmid M Boshart R Miksicek G Schutz 1987 Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene Cell 49 29 38 2881624 10.1016/0092-8674(87)90752-5 1:CAS:528:DyaL1cXltVCktQ%3D%3D
35. LG Luo T Bruhn IM Jackson 1995 Glucocorticoids stimulate thyrotropin-releasing hormone gene expression in cultured hypothalamic neurons Endocrinology 136 4945 4950 7588228 10.1210/en.136.11.4945 1:CAS:528: DyaK2MXovFOltro%3D
36. C Estupina J Belmar L Tapia-Arancibia H Astier S Arancibia 1997 Rapid and opposite effects of dexamethasone on in vivo and in vitro hypothalamic somatostatin release Exp Brain Res 113 337 342 9063719 10.1007/BF02450331 1:CAS:528:DyaK2sXitFWrtb0%3D
37. H Zaher CK Svensson 1994 Glucocorticoid induction of hepatic acetyl CoA:arylamine N-acetyltransferase activity in the rat Res Commun Chem Pathol Pharmacol 83 195 208 8202632 1:CAS:528:DyaK2cXitVyrsLw%3D
38. PT Reeves RF Minchin KF Ilett 1988 Induction of sulfamethazine acetylation by hydrocortisone in the rabbit Drug Metab Dispos 16 110 115 2894938 1:CAS:528:DyaL1cXht1Cks74%3D
39. IB Glowinski WW Weber 1982 Biochemical characterization of genetically variant aromatic amine N-acetyltransferases in A/J and C57BL/6J mice J Biol Chem 257 1431 1437 6976964 1:CAS:528:DyaL38XhtVWmtLs%3D
40. TN Smolen JA Brewer WW Weber 1993 Testosterone modulation of N-acetylation in mouse kidney J Pharmacol Exp Ther 264 854 858 8437129 1:CAS:528:DyaK3sXitVGnurc%3D
41. L Estrada KC Kanelakis GN Levy WW Weber 2000 Tissue- and gender-specific expression of N-acetyltransferase 2 (Nat2*) during development of the outbred mouse strain CD-1 Drug Metab Dispos 28 139 146 10640510 1:CAS:528:DC%2BD3cXot1WisQ%3D%3D
42. RB Evans-Storms JA Cidlowski 2000 Delineation of an antiapoptotic action of glucocorticoids in hepatoma cells: the role of nuclear factor-kappaB Endocrinology 141 1854 1862 10803596 10.1210/en.141.5.1854 1:CAS:528: DC%2BD3cXlt1WnsLc%3D
43. L Liu CD Klaassen 1996 Regulation of hepatic sulfotransferases by steroidal chemicals in rats Drug Metab Dispos 24 854 858 8869819 1:CAS:528:DyaK28XltFGnsbg%3D
44. Z Duanmu D Locke J Smigelski W Wu MS Dahn CN Falany TA Kocarek M Runge-Morris 2002 Effects of dexamethasone on aryl (SULT1A1)- and hydroxysteroid (SULT2A1)-sulfotransferase gene expression in primary cultured human hepatocytes Drug Metab Dispos 30 997 1004 12167565 10.1124/dmd.30.9.997 1:CAS:528:DC%2BD38XmsVShurk%3D
45. H Gong MJ Jarzynka TJ Cole JH Lee T Wada B Zhang J Gao WC Song DB DeFranco SY Cheng W Xie 2008 Glucocorticoids antagonize estrogens by glucocorticoid receptor-mediated activation of estrogen sulfotransferase Cancer Res 68 7386 7393 18794126 10.1158/0008-5472.CAN-08-1545 1:CAS:528: DC%2BD1cXhtFWltLfL
46. S Boukouvala G Fakis 2005 Arylamine N-acetyltransferases: what we learn from genes and genomes Drug Metab Rev 37 511 564 16257833 10.1080/ 03602530500251204 1:CAS:528:DC%2BD2MXhtFyqu7fL
47. L Estrada-Rodgers GN Levy WW Weber 1998 Characterization of a hormone response element in the mouse N-acetyltransferase 2 (Nat2*) promoter Gene Expr 7 13 24 9572394 1:CAS:528:DyaK1cXivVWht7g%3D